| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On July 19, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1994D-0025
|
| Interim GDL/Labeling Milk & Milk Products from Cows w/rbST
|
|
|
|
|
| 1994N-0355
|
| Quinine treatment/prevention of Malaria for OTC Human Use
|
|
|
|
|
| 1996N-0417
|
| CGMP in Mfg. Packing or Holding Dietary Supplements
|
|
|
|
|
| 2004P-0448
|
| DERMA-SMOORHE/FS(fluocinolone acetonide 0.01% topical oil)
|
|
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing & Handling of Food
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006P-0428
|
| Combivent (ipratropium bromide and albuterol sulfate)
|
|
|
|
|
| 2007D-0212
|
| Guidance for Industry on Malaria: Developing Drug and Nonvaccine Biological Products for Treatment and Prophylaxis
|
|
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
|
|
| 2007N-0155
|
| Defining and Implementing Quality in Clinical Investigations: From Design to Completion; Public Workshop
|
|
|
|
|
| 2007N-0186
|
| Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary
|
|
|
| |
|
|
|
| 2007P-0004
|
| Take steps to insure the safety of Americans regarding the misuses of Lasik
|
|
| |
|
| 1994D-0025
|
| Interim GDL/Labeling Milk & Milk Products from Cows w/rbST
|
|
|
|
|
| C 8590
|
| Dennis R. Mahoney & Alicia J. Mahoney
|
| Vol #:
|
| 116
|
|
| |
|
| 1994N-0355
|
| Quinine treatment/prevention of Malaria for OTC Human Use
|
|
|
|
|
| C 2
|
| Joseph K. Kiraly MD
|
| Vol #:
|
| 1
|
|
|
|
|
| 1996N-0417
|
| CGMP in Mfg. Packing or Holding Dietary Supplements
|
|
|
|
|
| C 252
|
| Russell Walker
|
| Vol #:
|
| 43
|
|
|
|
|
| C 253
|
| Wendy Wilson
|
| Vol #:
|
| 43
|
|
|
|
|
| C 254
|
| Phil Whitehead
|
| Vol #:
|
| 43
|
|
|
|
|
| C 255
|
| Loydelle McElyea
|
| Vol #:
|
| 43
|
|
|
|
|
| 2004P-0448
|
| DERMA-SMOOTHE/FS(fluocinolone acetonide 0.01% topical oil)
|
|
|
|
|
| LET 6
|
| Hill Dermaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing & Handling of Food
|
|
|
|
|
| C 1995
|
| J. Ly
|
| Vol #:
|
| 27
|
|
|
|
|
| C 1996
|
| L. Leibowitz
|
| Vol #:
|
| 27
|
|
|
|
|
| C 1997
|
| L. Romano
|
| Vol #:
|
| 27
|
|
|
|
|
| C 1998
|
| P. Hostetler
|
| Vol #:
|
| 27
|
|
|
|
|
| C 1999
|
| M. Daitzman
|
| Vol #:
|
| 27
|
|
|
|
|
| C 2000
|
| I. J. Barzak
|
| Vol #:
|
| 27
|
|
|
|
|
| C 2001
|
| D. Esposito
|
| Vol #:
|
| 27
|
|
|
|
|
| C 2002
|
| G. Smay
|
| Vol #:
|
| 27
|
|
| | | | | | | | |
|
| |
|
| C 2225
|
| D. Wilson
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2226
|
| D. Brooks
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2227
|
| S. Killay
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2228
|
| S. Hibshman
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2229
|
| L. G. Albano
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2230
|
| R. Parham
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2231
|
| B. Murphy
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2232
|
| J. A. Ishler
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2233
|
| R. Ang
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2234
|
| V. Fillingim
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2235
|
| D. Gregg
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2236
|
| B. Aldrich
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2237
|
| K. Reynolds
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2238
|
| S. Mcdermott
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2239
|
| D. Zwirtz
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2240
|
| C. Frey
|
| Vol #:
|
| 288
|
|
|
|
|
| C 2241
|
| R. Boersema
|
| Vol #:
|
| 28
|
|
|
|
|
| C 2242
|
| J. C. Melish
|
| Vol #:
|
| 28
|
|
| |
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| C 18327
|
| A. Laster
|
| Vol #:
|
| 198
|
|
|
|
|
| C 18328
|
| W. Sauls
|
| Vol #:
|
| 198
|
|
|
|
|
| 2006P-0428
|
| Combivent (ipratropium bromide and albuterol sulfate)
|
|
|
|
|
| C 4
|
| Alpha-1 Foundation
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007D-0212
|
| Guidance for Industry on Malaria: Developing Drug and Nonvaccine Biological Products for Treatment and Prophylaxis
|
|
|
|
|
| C 1
|
| World Health Organization
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007N-0121
|
| Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
|
|
|
|
|
| C 8
|
| Medicine Shoppe International, Inc.
|
| Vol #:
|
| 7
|
|
|
|
|
| C 9
|
| Mark de Bruin, R.Ph.
|
| Vol #:
|
| 7
|
|
|
|
|
| 2007N-0155
|
| Defining and Implementing Quality in Clinical Investigations: From Design to Completion; Public Workshop
|
|
|
|
|
| C 1
|
| AdvaMed
|
| Vol #:
|
| 1
|
|
| |
|
| 2007N-0186
|
| Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary
|
|
|
|
|
|
|
|
|
|
|
| C 1
|
| Dona Offemaria
|
| Vol #:
|
| 1
|
|